SPP1 and head and neck squamous cell carcinoma: Collectively, these findings strongly supported that TCP and GSK-J1 treatment increased the enrichment of H3K4me2 and H3K27me3 in SPP1 promoter region, in turn epigenetically impairing its transcription and inducing cells undergoing apoptosis in HNSCC.